K408-1085 Screening compound: 2-{4-[butyl(methyl)sulfamoyl]benzamido}-5,5,7,7-tetramethyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxamide

K408-1085 Screening compound: 2-{4-[butyl(methyl)sulfamoyl]benzamido}-5,5,7,7-tetramethyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxamide
K408-1085 Screening compound: 2-{4-[butyl(methyl)sulfamoyl]benzamido}-5,5,7,7-tetramethyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K408-1085
2-{4-[butyl(methyl)sulfamoyl]benzamido}-5,5,7,7-tetramethyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K408-1085

Molecular Formula

C24H34N4O4S2 (C24 H34 N4 O4 S2)

Compound Name

2-{4-[butyl(methyl)sulfamoyl]benzamido}-5,5,7,7-tetramethyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxamide

IUPAC name

2-{4-[butyl(methyl)sulfamoyl]benzamido}-5577-tetramethyl-4H5H6H7H-thieno[23-c]pyridine-3-carboxamide

SMILES

CCCCN(C)S(c(cc1)ccc1C(Nc1c(C(N)=O)c(CC(C)(C)NC2(C)C)c2s1)=O)(=O)=O

InChI

InChI=1S/C24H34N4O4S2/c1-7-8-13-28(6)34(31,32)16-11-9-15(10-12-16)21(30)26-22-18(20(25)29)17-14-23(2,3)27-24(4,5)19(17)33-22/h9-12,27H,7-8,13-14H2,1-6H3,(H2,25,29)(H,26,30)

InChI Key

SNBIIARGJJFOFJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09972397

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

506.69

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.855

Distribution Coefficient, logD

2.855

Water Solubility, LogSw

-3.52

Polar Surface Area

101.197

Acid Dissociation Constant (pKa)

5.35

Base Dissociation Constant (pKb)

7.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

K408-1085 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with K408-1085 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K408-1085?
Check Price and Availability of K408-1085, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K408-1085 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K408-1085
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K408-1085
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K408-1085 available by request